APA (7th ed.) Citation

K, M., M, C., AX, Z., F, P., MP, C., G, D., . . . P, N. (2020). Proteolysis-targeting chimeras in drug development: A safety perspective. British journal of pharmacology, 177(8), 1709. https://doi.org/10.1111/bph.15014

Chicago Style (17th ed.) Citation

K, Moreau, Coen M, Zhang AX, Pachl F, Castaldi MP, Dahl G, Boyd H, Scott C, and Newham P. "Proteolysis-targeting Chimeras in Drug Development: A Safety Perspective." British Journal of Pharmacology 177, no. 8 (2020): 1709. https://doi.org/10.1111/bph.15014.

MLA (9th ed.) Citation

K, Moreau, et al. "Proteolysis-targeting Chimeras in Drug Development: A Safety Perspective." British Journal of Pharmacology, vol. 177, no. 8, 2020, p. 1709, https://doi.org/10.1111/bph.15014.